I've repeatedly encountered research I'd have liked to use, but which was inaccessibly buried by the pipeline from academic research to patents, to optional fai

I've repeatedly encountered research I'd have liked to use, but which was inaccessibly buried by the pipeline from academic research to patents, to optional failed startup, to bigco portfolio entombment. And wished for an industrial policy dialed more towards a progression from research, to open source and community exploration, to cottage commercial, to small-scale industrial. Or consider a slider from non-competes, to California I'm-working-at-a-competitor-tomorrow, to China and-I've-brought-stuff - I'd like to see more California and China than not. Our optimization for pharma and VC, often seems terminally ill fitted for progress along many vectors.